FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month ended		Commission File Number
May 2007		1-32608

VIREXX MEDICAL CORP.

(Translation of registrant's name into English)

8223 Roper Road NW, Edmonton, Alberta, Canada T6E 6S4

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F

[X]

Form 40-F

[ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes

[ ]

[X]

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____

EXHIBIT INDEX

Exhibit

Number

Description of Exhibit

99.1	VIREXX ANNOUNCES COLLABORATION WITH THE NATIONAL INSTITUTE OF NANOTECHNOLOGY (NINT) AND DEFENCE RESEARCH AND DEVELOPMENT CANADA SUFFIELD (DRDC SUFFIELD) WITH NETWORKING AND FINANCIAL CONTRIBUTION

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

VIREXX MEDICAL CORP. Date: May 30, 2007			VIREXX MEDICAL CORP. Date: May 30, 2007
/s/ Peter Smetek			/s/ Tracy Smith

Peter Smetek Chairman			Tracy Smith Manager of Finance

VIREXX MEDICAL CORP 6-K